• 1
    Schifferli JA & Taylor RP. Physiological and pathological aspects of circulating immune complexes. Kidney Int 1989; 35:9931003.
  • 2
    Mannik M. Pathophysiology of circulating immune complexes. Arthritis Rheum 1982; 25:7837.
  • 3
    Kasai S, Akaike T, Kunimoto T, Nitta K. Superoxide anion production from mouse peritoneal macrophages stimulated with surface-bound IgG and immune complexes: adsorption characteristics of IgG in relationship to biological activity. Eur J Immunol 1982; 12:10547.
  • 4
    Bonney RJ, Naruns P, Davies P, Humes JL. Antigen–antibody complexes stimulate the synthesis and release of prostaglandins by mouse peritoneal macrophages. Prostaglandins 1979; 18:60516.
  • 5
    Rouzer CA, Scott WA, Hamill AL, Liu FT, Katz DH, Cohn ZA. Secretion of leukotriene C and other arachidonic acid metabolites by macrophages challenged with immunoglobulin E immune complexes. J Exp Med 1982; 156:107786.
  • 6
    Polat GL, Laufer J, Fabian I, Passwell JH. Cross-linking of monocyte plasma membrane Fc alpha, Fc gamma or mannose receptors induces TNF production. Immunology 1993; 80:28792.
  • 7
    Berger S, Balló H, Stutte HJ. Immune complex-induced interleukin-6, interleukin-10 and prostaglandin secretion by human monocytes: a network of pro- and anti-inflammatory cytokines dependent on the antigen: antibody ratio. Eur J Immunol 1996; 26:1297301.
  • 8
    Nitta T & Suzuki T. Biochemical signals transmitted by Fc-gamma receptors: triggering mechanisms of the increased synthesis of adenosine-3′, 5′-cyclic monophosphate mediated by Fc-gamma2a- and Fc-gamma2b-receptors of a murine macrophage-like cell line (P388D1). J Immunol 1982; 129:270814.
  • 9
    Ravetch JV & Kinet JP. Fc receptors. Annu Rev Immunol 1991; 9:45792.
  • 10
    Clynes R & Ravetch JV. Cytotoxic antibodies trigger inflammation through Fc receptors. Immunity 1995; 3:216.
  • 11
    Daëron M. Fc receptor biology. Annu Rev Immunol 1997; 15:20334.
  • 12
    Virgin HW, Wittenberg GF, Unanue ER. Immune complex effects on murine macrophages. I. Immune complexes suppress interferon-γ induction of Ia expression. J Immunol 1985; 135:373543.
  • 13
    Revel M & Chebath J. Interferon-activated genes. Trends Biochem Sci 1986; 11:16670.
  • 14
    Hanaumi K, Gray P, Suzuki T. Fcγ receptor-mediated supression of γ-interferon-induced Ia antigen expression on a murine macrophage-like cell line (P338D1). J Immunol 1984; 133:28526.
  • 15
    Farraf MA & Schreiber RD. The molecular cell biology of interferon-γ and its receptor. Annu Rev Immunol 1993; 11:571611.
  • 16
    Rosa FM, Cochet MM, Fellous M. Interferon and major histocompatibility complex genes: a model to analyse eukaryotic gene regulation? Interferon 1986; 7:4887.
  • 17
    Van Weyenbergh J, Lipinski P, Abadie A et al. Antagonistic action of IFN-β and IFN-γ on high affinity Fcγ receptor expression in healthy controls and multiple sclerosis patients. J Immunol 1998; 161:156874.
  • 18
    Esparza I, Green R, Schreiber RD. Inhibition of macrophage tumoricidal activity by immune complexes and altered erythrocytes. J Immunol 1983; 131:211721.
  • 19
    Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 1968; 97:7789.
  • 20
    Balaji KN & Boom WH. Processing of Mycobacterium tuberculosis bacilli by human monocytes for CD4+αβ and γδ T cells: role of particulate antigen. Infect Immun 1998; 66:98106.
  • 21
    Perussia B, Dayton ET, Lazarus R, Fanning V, Trinchieri G. Immune interferon induces the receptor for monomeric IgG1 on human monocytic and myeloid cells. J Exp Med 1983; 158:1092113.
  • 22
    James F, Brouquisse R, Suire C, Pradet A, Raymond P. Purification and biochemical characterization of a vacuolar serine endopeptidase induced by glucose starvation in maize roots. Biochem J 1996; 320:28392.
  • 23
    Eid M, Evin G, Castro B, Menard J, Corvol P. New renin inhibitors homologous with pepstatin. Biochem J 1981; 197:46571.
  • 24
    Barnes K, Shimada K, Takahashi M, Tanzawa K, Turner AJ. Metallopeptidase inhibitors induce an up-regulation of endothelin-converting enzyme levels and its redistribution from the plasma membrane to an intracellular compartment. J Cell Sci 1996; 109:91928.
  • 25
    Savory PJ & Rivett AJ. Leupeptin-binding site(s) in the mammalian multicatalytic proteinase complex. Biochem J 1993; 289:458.
  • 26
    Tripp CS, Beckerman KP, Unanue ER. Immune complexes inhibit antimicrobial responses through interleuquin-10 production. Effects in severe combined immunodeficient mice during Listeria infection. J Clin Invest 1995; 95:162834.
  • 27
    Cresswell P. Antigen presentation. Getting peptides into MHC class II molecules. Curr Biol 1994; 4:5413.
  • 28
    Feldman GM, Chuang EJ, Finbloom DS. IgG immune complexes inhibit IFN-γ-induced transcription of the FcγRI gene in human monocytes by preventing the tyrosine phosphorylation of the p91 (Stat1) transcription factor. J Immunol 1995; 154:31825.
  • 29
    Bazil V. Physiological enzymatic cleavage of leukocyte membrane molecules. Immunol Today 1995; 16:13540.
  • 30
    Alves-Rosa MF, Vulcano M, Beigier M, Breyer I, Isturiz MA. The down-regulation of FcγRII and FcγRIIIB by N-formyl-methionyl-leucyl-phenylalanine (FMLP) depends on secretory events in human neutrophils. Immunol Lett 1999; 70:11926.DOI: 10.1016/s0165-2478(99)00125-x
  • 31
    Celada A. Immune-complex inhibition of macrophage activation is not due to an interaction with the binding or processing of IFN-γ. Immunology 1988; 64:18792.
  • 32
    Mui AL, Kay RJ, Humphries RK, Krystal G. Ligand-induced phosphorylation of the murine interleukin 3 receptor signals its cleavage. Proc Natl Acad Sci USA 1992; 89:108126.
  • 33
    Hintzen RQ, Lens SM, Beckmann MP, Goodwin RG, Lynch D, Van Lier RA. Characterization of the human CD27 ligand, a novel member of the TNF gene family. J Immunol 1994; 152:176273.
  • 34
    Demaria S, Schwab R, Gottesman SR, Bushkin Y. Soluble beta 2-microglobulin-free class I heavy chains are released from the surface of activated and leukemia cells by a metalloprotease. J Biol Chem 1994; 269:668994.